Medistim ASA (OSL: MEDI)

Medistim ASA Income Statement

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	541.82	521.11	486.26	417.82	356.21	356.91
Revenue Growth (YoY)	2.83%	7.17%	16.38%	17.30%	-0.20%	10.50%
Cost of Revenue	114.23	112.28	106.49	97.11	76.58	80.14
Gross Profit	427.6	408.83	379.78	320.7	279.63	276.78
Selling, General & Admin	166.01	150.2	136.51	124.02	108.39	116.08
Other Operating Expenses	109.09	103.53	78.73	62.27	52.61	52.91
Operating Expenses	300.11	277.39	238.53	209.72	184.15	187.01
Operating Income	127.49	131.44	141.25	110.99	95.48	89.77
Interest Expense	-0.15	-0.15	-0.12	-0.18	-0.15	-0.44
Interest & Investment Income	4.06	3.28	0.92	0.02	0.01	0.18
Currency Exchange Gain (Loss)	1.19	0.93	3.06	-1.81	-3.48	1.71
Other Non Operating Income (Expenses)	-0.25	-0.28	0.94	-0.24	-0.26	-0.18
EBT Excluding Unusual Items	132.34	135.21	146.05	108.78	91.61	91.04
Other Unusual Items	-	-	-	5.29	-	-
Pretax Income	132.34	135.21	146.05	114.07	91.61	91.04
Income Tax Expense	30.7	31.39	32.08	23.17	22.22	20.74
Net Income	101.64	103.82	113.97	90.9	69.39	70.31
Net Income to Common	101.64	103.82	113.97	90.9	69.39	70.31
Net Income Growth	-13.27%	-8.91%	25.38%	31.00%	-1.31%	23.22%
Shares Outstanding (Basic)	18	18	18	18	18	18
Shares Outstanding (Diluted)	18	18	18	18	18	18
Shares Change (YoY)	0.17%	0.10%	0.15%	0.07%	0.13%	-0.01%
EPS (Basic)	5.55	5.68	6.25	4.99	3.81	3.87
EPS (Diluted)	5.55	5.67	6.24	4.98	3.80	3.86
EPS Growth	-13.41%	-9.13%	25.30%	31.05%	-1.55%	23.32%
Free Cash Flow	100.34	96.79	104.24	119.97	66.68	66.7
Free Cash Flow Per Share	5.48	5.29	5.70	6.57	3.66	3.66
Dividend Per Share	4.500	4.500	4.500	3.750	3.000	2.750
Dividend Growth	0%	0%	20.00%	25.00%	9.09%	22.22%
Gross Margin	78.92%	78.45%	78.10%	76.76%	78.50%	77.55%
Operating Margin	23.53%	25.22%	29.05%	26.56%	26.81%	25.15%
Profit Margin	18.76%	19.92%	23.44%	21.76%	19.48%	19.70%
Free Cash Flow Margin	18.52%	18.57%	21.44%	28.71%	18.72%	18.69%
EBITDA	141.67	146.72	157.45	127.26	105.06	102.13
EBITDA Margin	26.15%	28.15%	32.38%	30.46%	29.49%	28.61%
D&A For EBITDA	14.18	15.27	16.2	16.27	9.57	12.36
EBIT	127.49	131.44	141.25	110.99	95.48	89.77
EBIT Margin	23.53%	25.22%	29.05%	26.56%	26.81%	25.15%
Effective Tax Rate	23.20%	23.21%	21.96%	20.31%	24.25%	22.78%
Revenue as Reported	526.36	526.36	491.94	427.28	363.13	363.72

Source: S&P Capital IQ. Standard template. Financial Sources.